ASCO 2013 - Poster: A phase I study of the safety and pharmacokinetics of DSTP3086S, an anti-STEAP1 antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer
American Society of Clinical Oncology (ASCO) 2018 – Poster | Sutro Biopharma, Inc.
ASCO 2020 - Epic Sciences
American Society of Clinical Oncology (ASCO) 2018 – Poster | Sutro Biopharma, Inc.
ASCO 2020 - Epic Sciences
ASCO 2013 - Poster: Impact of prior docetaxel (D) on sipuleucel-T (sip-T) product parameters in PROCEED patients
ASCO Poster – Theralase Technologies
Moh'd khushman on X: "Visit our posters @ASCO https://t.co/JbnosQ7USL" / X
Posters ASCO 2023
ASCO 2018-3 | NantOmics
ASCO 2013 - Poster: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data
ASCO 2020 - Elevar Therapeutics
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019 - VBI Vaccines
ASCO SITC 2019 - Elevar Therapeutics
ASCO 2022 - PSB205 - poster 414 - Sound Biologics
ASCO Poster Kiefer - systems-oncology
Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated | Business Wire
ASCO 2022 Poster
ASCO Quality Care Symposium Poster - Carevive - cancer care management & patient engagement tools
PlatformQ Health Presents Poster at ASCO Quality Care Symposium
Ocean Genomics Poster - ASCO 2023 with Yale Cancer Center - Identifying Molecular Predictors and Immunomodulatory Role of Dual Checkpoint Inhibitors in Small Cell Lung Cancer - Ocean Genomics